Achieve Life Sciences, Inc. Operating Expenses
Achieve Life Sciences, Inc. (ACHV) reported Operating Expenses of $7.37 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2016-05-12
- Achieve Life Sciences, Inc. operating expenses for the quarter ending 2016-03-31 was $7.37M, a 15.71% increase year-over-year.
- Achieve Life Sciences, Inc. operating expenses for the quarter ending 2015-12-31 was $9.50M, a 22.85% decline year-over-year.
- Achieve Life Sciences, Inc. operating expenses for the quarter ending 2015-09-30 was $11.43M, a 5.12% decline year-over-year.
- Achieve Life Sciences, Inc. operating expenses for the quarter ending 2015-03-31 was $6.37M.
- Achieve Life Sciences, Inc. operating expenses for fiscal 2015 was $36.91M, a 34.76% decline from fiscal 2014.
- Achieve Life Sciences, Inc. operating expenses for fiscal 2014 was $56.58M, a 13.23% decline from fiscal 2013.
- Achieve Life Sciences, Inc. operating expenses for fiscal 2013 was $65.21M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2016-03-31 | $7.37M 10-Q · filed 2016-05-12 | $16.88M derived: sum of 2 quarters · filed 2016-05-12 | $28.30M derived: sum of 3 quarters · filed 2016-05-12 | |
| 2015-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $20.93M derived: sum of 2 quarters · filed 2016-03-09 | $36.91M 10-K · filed 2016-03-09 | |
| 2015-09-30 | $11.43M 10-Q · filed 2015-11-12 | $27.41M 10-Q · filed 2015-11-12 | ||
| 2015-03-31 | $6.37M 10-Q · filed 2016-05-12 | $18.69M derived: sum of 2 quarters · filed 2016-05-12 | $30.73M derived: sum of 3 quarters · filed 2016-05-12 | |
| 2014-12-31 | $12.32M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $24.36M derived: sum of 2 quarters · filed 2016-03-09 | $56.58M 10-K · filed 2016-03-09 | |
| 2014-09-30 | $12.04M 10-Q · filed 2015-11-12 | $44.26M 10-Q · filed 2015-11-12 | ||
| 2013-12-31 | $65.21M 10-K · filed 2016-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |